Paper23948467
Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.
Hausner M and 4 others. Microb Pathog, 2013. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan. Papers, record 23948467. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23948467
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of protective anti-Mycoplasma pneumoniae antibodies after immunization of guinea pigs with the combination of a P1-P30 chimeric recombinant protein and chitosan.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adhesins, Bacterial | Major topic |
| Adjuvants, Immunologic | Major topic |
| Antibodies, Bacterial | Major topic |
| Bacterial Vaccines | Major topic |
| Chitosan | Major topic |
| Mycoplasma pneumoniae | Major topic |
| Administration, Intranasal | |
| Animals | |
| Bacterial Adhesion | |
| Bacterial Load | |
| Disease Models, Animal | |
| Epithelial Cells | |
| Guinea Pigs | |
| HeLa Cells | |
| Humans | |
| Injections, Subcutaneous | |
| Lung | |
| Pneumonia, Mycoplasma | |
| Recombinant Proteins | |
| Vaccination | |
| Vaccines, Synthetic |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42840255 | A multi-epitope vaccine targeting Mycoplasma pneumoniae P1 adhesin and CARDS toxin confers synergistic protection by adhesion inhibition and toxin neutralization. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840255 | PubMed |
| 42042806 | Three-Component Subunit Vaccine Induces Protective Immunity Against Mycoplasma pneumoniae in Mice. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42042806 | PubMed |
| 41822501 | Immune dysregulation in Mycoplasma pneumoniae pneumonia: mechanistic controversies and clinical translation from inflammatory dysregulation and immune evasion to chronic injury. | Front Immunol | 2026 | https://conductscience.org/library/papers/41822501 | PubMed |
| 41438744 | Development of human mycoplasma vaccines: navigating the IL-17A paradox. | Front Immunol | 2025 | https://conductscience.org/library/papers/41438744 | PubMed |
| 41156647 | Therapeutic Efficacy of an Anti-P116-661 Polyclonal Antibody Against Mycoplasma pneumoniae Infection. | Pathogens | 2025 | https://conductscience.org/library/papers/41156647 | PubMed |
| 41012172 | Adjuvant Mucosal Strategies Confer Safe and Effective Immunity Against Mycoplasma pneumoniae and Overcome Vaccine-Associated Enhanced Lung Pathology. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/41012172 | PubMed |
| 40771685 | Advances in adhesion-related pathogenesis in Mycoplasma pneumoniae infection. | Front Microbiol | 2025 | https://conductscience.org/library/papers/40771685 | PubMed |
| 40469165 | Changes of serum inflammatory markers and immune function in children with bronchial asthma complicated with mycoplasma pneumoniae infection before and after treatment and their clinical significance. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/40469165 | PubMed |
| 39735188 | Reviewing advancement in Mycoplasma pneumoniae P30 adhesin protein provides insights for future diagnosis and treatment. | Front Microbiol | 2024 | https://conductscience.org/library/papers/39735188 | PubMed |
| 39291404 | Research of recombinant influenza A virus as a vector for Mycoplasma pneumoniae P1a and P30a. | Immun Inflamm Dis | 2024 | https://conductscience.org/library/papers/39291404 | PubMed |
| 38765654 | Exploring the pathogenetic mechanisms of Mycoplasmapneumoniae (Review). | Exp Ther Med | 2024 | https://conductscience.org/library/papers/38765654 | PubMed |
| 35646746 | Mycoplasmas as Host Pantropic and Specific Pathogens: Clinical Implications, Gene Transfer, Virulence Factors, and Future Perspectives. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35646746 | PubMed |
| 33503845 | Mycoplasma pneumoniae Infections: Pathogenesis and Vaccine Development. | Pathogens | 2021 | https://conductscience.org/library/papers/33503845 | PubMed |
| 32286369 | Cell surface processing of the P1 adhesin of Mycoplasma pneumoniae identifies novel domains that bind host molecules. | Sci Rep | 2020 | https://conductscience.org/library/papers/32286369 | PubMed |
| 31611272 | Toll-Like Receptor 2 (TLR2) and TLR4 Mediate the IgA Immune Response Induced by Mycoplasma hyopneumoniae. | Infect Immun | 2019 | https://conductscience.org/library/papers/31611272 | PubMed |
| 30396892 | Antibodies to Protein but Not Glycolipid Structures Are Important for Host Defense against Mycoplasma pneumoniae. | Infect Immun | 2019 | https://conductscience.org/library/papers/30396892 | PubMed |
| 29749357 | Mycoplasma pneumoniae: A significant but underrated pathogen in paediatric community-acquired lower respiratory tract infections. | Indian J Med Res | 2018 | https://conductscience.org/library/papers/29749357 | PubMed |
| 27667580 | Insights into the pathogenesis of Mycoplasma pneumoniae (Review). | Mol Med Rep | 2016 | https://conductscience.org/library/papers/27667580 | PubMed |
| 27537186 | Elongation Factor Tu and Heat Shock Protein 70 Are Membrane-Associated Proteins from Mycoplasma ovipneumoniae Capable of Inducing Strong Immune Response in Mice. | PLoS One | 2016 | https://conductscience.org/library/papers/27537186 | PubMed |
| 27148202 | A Compendium for Mycoplasma pneumoniae. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27148202 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CENPV | 201161 | PubTator's text mining | https://conductscience.org/library/genes/201161 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23948467
GET https://conductscience.org/api/papers/v1/23948467/cited_by?page=2